Men’s Hormonal Health After 40: Everything You Need to Know

Something shifts in a man’s body in his 40s that most men can feel but few can name. Energy that used to be reliable starts fluctuating. Body composition changes despite no obvious change in habits. Mood and motivation become less consistent. Recovery from exercise slows. The changes are real — but the explanation is rarely offered clearly.

The honest explanation is hormonal. The key hormones that govern men’s energy, body composition, sexual function, mood, and long-term metabolic health — testosterone, growth hormone, cortisol, thyroid hormones — all shift in meaningful ways during and after the fifth decade. Understanding what’s changing, why it’s changing, what symptoms it produces, and what clinical options exist to address it is the purpose of this guide.

The Hormonal Landscape of Men’s Health After 40

Men’s hormonal health after 40 isn’t a single issue — it’s the product of several hormonal systems that change on different timelines and produce overlapping but distinct symptom patterns. The most clinically significant shifts involve testosterone, growth hormone, cortisol, and thyroid function.

Testosterone: The most discussed, most commonly deficient

Total testosterone declines at approximately 1–2% per year from the mid-30s onward — a gradual slope that accelerates in some men and stays shallow in others. By 50, the average man has meaningfully lower testosterone than he did at 25 — and a significant proportion fall below the clinical threshold for hypogonadism.

What makes testosterone deficiency clinically important isn’t just symptoms — it’s the downstream effects on metabolic health, cardiovascular risk, bone density, and mortality risk that longstanding deficiency produces. The article on testosterone levels and mortality risk covers the long-term health data. For a full clinical overview of testosterone deficiency and its management, the complete TRT guide is the primary reference.

Growth hormone: The underdiagnosed deficiency

Growth hormone secretion declines with age — but clinical GH deficiency in adults is a distinct entity caused by pituitary or hypothalamic pathology, not simply by aging. Men with a history of pituitary disease, brain surgery, radiation, or traumatic brain injury are at particular risk. The overlap in symptoms between GH deficiency and testosterone deficiency — fatigue, body composition changes, reduced quality of life — means GH deficiency is frequently missed in men whose testosterone is addressed but symptoms don’t fully resolve.

The signs of low growth hormone and the full overview of HGH therapy for men are covered in the 7 signs of low GH and the HGH therapy overview.

Cortisol: The stress axis disruption

Chronic psychological and physiological stress elevates cortisol, which directly suppresses testosterone production through multiple pathways — including HPG axis suppression and increased aromatization of testosterone to estrogen. Many men in their 40s are at peak career and life stress simultaneously with the period of natural hormonal decline, creating a compound effect that worsens both testosterone and GH deficiency.

Thyroid function

Hypothyroidism — underactive thyroid — becomes more common with age in men and produces symptoms identical to testosterone deficiency: fatigue, weight gain, cognitive slowing, mood changes, reduced libido. It is one of the most important conditions to rule out in any evaluation of hormonal symptoms. Thyroid testing should be standard in any hormone workup after 40.

The Symptom Picture: What Men Actually Experience

The challenge with hormonal symptoms in men over 40 is not that they’re subtle — it’s that they accumulate gradually enough that most men adapt to the new normal before realizing something has changed. The comparison point isn’t last month; it’s 10 years ago.

For a focused exploration of how the fatigue-irritability-libido symptom cluster presents and what it signals hormonally, the article on hormonal symptoms that aren’t always recognized as such covers the differential picture. For men whose primary complaint is persistent fatigue, the specific testosterone connection is explored in the fatigue and testosterone guide.

Testosterone After 40: Diagnosis and What It Requires

Testosterone deficiency — clinical hypogonadism — requires both biochemical confirmation and symptomatic presentation. Neither alone is sufficient for appropriate diagnosis and treatment initiation under current clinical guidelines.

The diagnostic requirements include two separate morning testosterone measurements (testosterone peaks between 7–10 AM), LH and FSH to identify whether the problem is at the testicular or pituitary level, prolactin to rule out pituitary tumors, free testosterone and SHBG for men with borderline total testosterone, and thyroid function to exclude overlapping causes.

The full pre-treatment lab workup — what each test does, why it’s needed, and how to prepare — is covered in detail in the complete TRT lab guide. What to expect at the first consultation is covered in the first TRT consultation guide.

Table 1 — Key hormones affecting men’s health after 40. Each requires distinct diagnostic tests and treatment approaches. Overlap in symptoms makes laboratory testing essential for accurate attribution.

Testosterone Replacement Therapy: The Treatment Decision

For men with confirmed hypogonadism — two low morning testosterone readings combined with symptomatic presentation — TRT is the standard of care. The decision involves selecting a delivery method, initiating monitoring, and understanding the timeline for results.

Delivery method options

TRT is available in multiple forms, each with different pharmacokinetics, convenience, and practical tradeoffs. The main options include weekly or twice-weekly subcutaneous injections (testosterone cypionate or enanthate), daily topical gels or creams, transdermal patches, and pellet implants inserted every 3–6 months. A detailed comparison of injections versus pellets — the two most commonly debated options — is covered in the pellets vs. injections guide.

What to expect from TRT

TRT produces different benefits on different timelines — libido and energy typically improve within weeks, while body composition changes develop over months and bone density over years. Understanding the realistic timeline prevents premature discontinuation. The full symptom-by-symptom timeline is covered in the TRT results timeline guide.

Where to get care

The choice between an online TRT platform and a traditional in-person clinic involves real tradeoffs in cost, access, diagnostic depth, and care complexity. The full comparison is in the online vs. local TRT clinic guide. For cost expectations by care model and delivery method, the TRT cost breakdown covers current U.S. pricing.

How to get started

The step-by-step process from recognizing symptoms to evaluation to treatment initiation is covered in the step-by-step TRT guide.

Weight, Body Composition, and Hormones: The Interconnection

One of the most clinically significant consequences of male hormonal decline after 40 is the body composition shift — increased visceral fat, reduced lean mass, and slowed metabolism. This is not simply a consequence of aging or lifestyle; it is a direct metabolic effect of testosterone and growth hormone deficiency.

The mechanism is bidirectional: low testosterone promotes visceral fat accumulation, and visceral fat increases aromatase activity — converting testosterone to estrogen — which further suppresses testosterone production. This cycle is why many men find that conventional caloric restriction and exercise produce diminishing returns in their 40s compared to earlier years. The full explanation of this cycle is in the article on whether low testosterone causes weight gain.

For men where pharmacological weight management is also part of the clinical picture, GLP-1 receptor agonists — semaglutide and tirzepatide — represent the most evidence-supported pharmacological options currently available. These work through entirely different mechanisms than hormonal therapy and can be used concurrently when clinically appropriate. The overview is in the GLP-1 therapy guide and the semaglutide vs tirzepatide comparison. The broader weight management overview is at the weight loss services page.

Sexual Health After 40: The Hormonal Component

Reduced sexual function — whether it presents as reduced desire, erectile changes, or both — is among the most common and most distressing presentations of hormonal decline in men after 40. It is also among the most frequently misattributed, because psychological, relationship, vascular, and neurological factors overlap with hormonal causes in ways that make identification without laboratory testing unreliable.

Testosterone deficiency is the primary hormonal driver of reduced libido. Erectile dysfunction has both hormonal and vascular components — and the two frequently coexist, requiring evaluation of both. The hormonal evaluation for ED is covered in the article on erectile dysfunction and hormones, and the specific relationship between low libido and hormonal causes is in the low libido guide.

Beyond testosterone, the peptide bremelanotide (PT-141) addresses sexual desire through a central nervous system mechanism — distinct from the vascular mechanism of conventional ED medications. The full overview of sexual health services and how different treatments are integrated is at the sexual health overview.

Peptide Therapy: What Role Does It Play After 40?

Peptide therapy has become an increasingly visible component of men’s health care after 40 — not as a replacement for hormonal therapy, but as a complementary approach addressing specific systems. Several categories are relevant:

GH secretagogue peptides (Sermorelin, CJC-1295, Ipamorelin) stimulate the pituitary to produce more growth hormone — relevant for men with sub-optimal GH output who don’t meet the diagnostic threshold for confirmed AGHD requiring direct HGH replacement. For a full comparison of these peptides and how they differ from each other and from direct HGH, see the peptide comparison guide and the peptide therapy overview. A plain-English introduction to how peptides work as a drug class is in the peptide guide for men over 35.

Tissue repair peptides (BPC-157) address musculoskeletal recovery and anti-inflammatory pathways — relevant for active men dealing with injury or recovery limitation.

Sexual health peptides (PT-141) address central arousal pathways independently of hormonal status.

Peptide therapy is most effective when hormonal deficiencies have been addressed first — peptides complement an optimized hormonal foundation but don’t substitute for it.

Table 2 — Clinical goals and treatment approaches for men’s hormonal health after 40. All decisions require physician evaluation and laboratory confirmation of deficiency. These are orientation frameworks, not prescribing guidance.

The Evaluation: Where to Start

The most common mistake men make when approaching hormonal health after 40 is starting with treatment assumptions rather than diagnostic clarity. The right starting point is a comprehensive evaluation — not a TRT consultation, not a peptide subscription, but a clinical assessment of which systems are actually deficient.

For the comparison between HGH and TRT — when each is appropriate and how they differ — the HGH vs TRT guide covers the clinical decision framework. For monitoring and side effects once treatment is underway, the TRT side effects guide and the hematocrit monitoring guide cover ongoing management.

Frequently Asked Questions

At what age should men start getting hormone levels checked?

There’s no universal age at which hormonal screening becomes mandatory — the trigger is symptoms, not a birthday. Men who are experiencing meaningful fatigue, body composition changes despite reasonable lifestyle, reduced libido, mood changes, or cognitive fog in their late 30s or 40s have clinical justification for a hormone panel regardless of age. Men without symptoms don’t need screening simply because they’ve turned 40. For men with a family history of early hypogonadism or a history of pituitary disease, earlier proactive screening is reasonable.

How do I know if my symptoms are hormonal or something else?

You can’t know reliably from symptoms alone — and neither can a physician. That’s precisely why laboratory testing matters. Depression, thyroid dysfunction, sleep apnea, anemia, insulin resistance, and hormonal deficiency all produce overlapping symptoms. The clinical value of a comprehensive panel is that it either confirms a hormonal cause (allowing targeted treatment) or rules it out (directing attention to non-hormonal causes). Starting treatment based on symptom pattern without lab confirmation is guesswork — and the wrong diagnosis leads to the wrong treatment.

Can lifestyle changes fix hormonal decline?

Lifestyle factors — resistance training, sleep, weight management, stress reduction, nutrition — significantly influence testosterone and GH levels and should always be part of the picture. For men with borderline levels, meaningful lifestyle improvements can sometimes push levels into functional ranges. For men with confirmed clinical hypogonadism, lifestyle optimization supports but does not substitute for hormonal therapy. The relationship between weight, hormones, and lifestyle is covered in the article on low testosterone and weight gain.

Do I need to be on hormone therapy forever?

For men with primary hypogonadism — where the testes themselves are the source of failure — the deficiency is typically permanent and ongoing therapy is required for sustained benefit. For some men with secondary hypogonadism driven by reversible causes (obesity, medication, sleep apnea), addressing the underlying cause may allow dose reduction or discontinuation. This is why identifying the type of hypogonadism (primary vs. secondary via LH/FSH) at diagnosis matters — it affects the long-term treatment picture.

Are there natural ways to boost testosterone?

Several lifestyle factors support testosterone production: consistent resistance training, adequate sleep (7–9 hours), healthy body weight, reduced alcohol consumption, stress management, and sufficient dietary fat and zinc. These interventions produce modest T-supporting effects in men with low-normal levels — they won’t normalize clinically low testosterone in men with confirmed hypogonadism, but they create a more favorable hormonal environment alongside any treatment. Supplements marketed as “testosterone boosters” have very limited evidence for meaningful clinical effect.

What is the difference between TRT and peptide therapy?

TRT directly replaces testosterone — correcting the primary hormonal deficiency. Peptide therapy targets different systems: GH secretagogue peptides support GH axis function, BPC-157 addresses tissue repair, PT-141 addresses sexual arousal centrally. They’re complementary tools, not alternatives. Peptide therapy is most effective when layered onto an optimized hormonal foundation — using peptides to compensate for unaddressed testosterone deficiency generally produces suboptimal results. A plain-English overview of peptides is in the peptide guide for men over 35.

Can I get all of this care in one place?

Comprehensive men’s hormonal health care — encompassing testosterone evaluation, GH axis assessment, weight management, and sexual health — is increasingly available through specialized men’s health clinics and some telemedicine platforms. General practitioners typically have limited scope in this area. When evaluating a provider, look for: comprehensive initial lab panels, appropriate diagnostic standards (two testosterone readings for hypogonadism, stimulation testing for AGHD), structured monitoring protocols, and willingness to address multiple systems rather than a single treatment offering. For how to navigate the provider landscape, the online vs. local clinic guide covers the tradeoffs.

How does men’s hormonal health compare to women’s hormone therapy?

Men’s and women’s hormonal health after 40 share structural similarities — both involve age-related hormonal decline affecting body composition, mood, energy, and sexual function — but the specific hormones, the rate of change, the symptom patterns, and the treatment approaches differ significantly. Women’s perimenopause involves a more rapid and dramatic hormonal shift concentrated around a defined biological event (menopause); men’s decline is more gradual and less clearly delineated. Both deserve the same clinical rigor in evaluation and treatment. For women’s hormonal health specifically, the women’s hormone therapy guide covers the parallel picture.

References

1. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744. doi:10.1210/jc.2018-00229
2. Wu FC, Tajar A, Beynon JM, et al. Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men. N Engl J Med. 2010;363(2):123–135. doi:10.1056/NEJMoa0911101
3. Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE). N Engl J Med. 2023;389(2):107–117. doi:10.1056/NEJMoa2215025
4. Molitch ME, Clemmons DR, Malozowski S, et al. Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96(6):1587–1609. doi:10.1210/jc.2011-0179
5. Corona G, Giagulli VA, Maseroli E, et al. Testosterone supplementation and body composition: results from a meta-analysis study. Eur J Endocrinol. 2016;174(3):R99–R116. doi:10.1530/EJE-15-0262
6. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab. 2001;86(2):724–731. doi:10.1210/jcem.86.2.7219
7. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423–432. doi:10.1016/j.juro.2018.03.115